Security key
D2734Z107
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 678
- Total 13F value
- $33,000
- Share change
- 0
- SEC-reported price per share
- $48.67
- Number of holders
- 1
- Shares outstanding
- 268,958,280
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2017
Institutions
1
Top holders
1
D2734Z107 full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Fresenius Medical Care AG SEC filings
Fresenius Medical Care AG company facts
Fresenius Medical Care AG 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP D2734Z107
Recent filing periods:
Ownership snapshot
Top reported holders of D2734Z107 - FRESENIUS MEDICAL CARE AG - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
HARDING LOEVNER LP
Disclosed value leader
HARDING LOEVNER LP
Comparable rows
0/15
Latest evidence
31 Mar 2017
13F
Highest disclosed value: $148,675,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
HARDING LOEVNER LP has the largest disclosed position value at $148.68M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens HARDING LOEVNER LP's linked filing trail.
Disclosed position value
Top 5
HARDING LOEVNER LP
$148.68M
CAMBIAR INVESTORS LLC
$106.02M
BANK OF AMERICA CORP /DE/
$62.92M
NORTHERN TRUST CORP
$39.55M
MORGAN STANLEY
$29.96M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| HARDING LOEVNER LP |
13F
Company
|
—
denominator unverified
|
$148,675,000
3,528,960 shares
|
— | 31 Mar 2017 |
| CAMBIAR INVESTORS LLC |
13F
Company
|
—
denominator unverified
|
$106,017,000
2,516,416 shares
|
— | 31 Mar 2017 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
—
denominator unverified
|
$62,917,000
1,493,411 shares
|
— | 31 Mar 2017 |
| NORTHERN TRUST CORP |
13F
Company
|
—
denominator unverified
|
$39,554,000
938,840 shares
|
— | 31 Mar 2017 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$29,958,000
711,099 shares
|
— | 31 Mar 2017 |
| MARATHON ASSET MANAGEMENT LLP |
13F
Company
|
—
denominator unverified
|
$26,671,000
630,548 shares
|
— | 31 Mar 2017 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
678
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2017 vs Q2 2026 Across Filers
Q2 2026 holders
1
Q2 2017 holders
1
Holder diff
0
| Investor | Q2 2026 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q2 2026 value | Q2 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend